Theratechnologies Inc. (THTX)
2.58
0.64 (32.99%)
At close: Apr 14, 2025, 3:59 PM
2.44
-5.43%
After-hours: Apr 14, 2025, 07:59 PM EDT
32.99% (1D)
| Bid | 2.42 |
| Market Cap | 118.63M |
| Revenue (ttm) | 85.7M |
| Net Income (ttm) | -8.26M |
| EPS (ttm) | -0.07 |
| PE Ratio (ttm) | -36.86 |
| Forward PE | 28.93 |
| Analyst | n/a |
| Ask | 2.48 |
| Volume | 58,676,126 |
| Avg. Volume (20D) | 1,879,529 |
| Open | 2.59 |
| Previous Close | 1.94 |
| Day's Range | 2.55 - 3.13 |
| 52-Week Range | 1.08 - 3.13 |
| Beta | 1.50 |
About THTX
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant ...
Sector Healthcare
IPO Date Feb 13, 2009
Employees 103
Stock Exchange NASDAQ
Ticker Symbol THTX
Website https://www.theratech.com
Earnings Surprise
Theratechnologies has released their quartely earnings
on Apr 9, 2025:
1 day ago
+32.47%
Theratechnologies shares are trading higher after ...
Unlock content with
Pro Subscription
4 days ago
+45.86%
Theratechnologies shares are trading higher following Future Pak's proposal to acquire the company for $255 million.
